Cited by 888Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.

Diabetic dyslipidaemia: from basic research to clinical practice*

Open access

Taskinen, M.-R.·2003·Diabetologia

DOI 10.1007/s00125-003-1111-y

Open this paper in CoChat — free account Open PDF

Abstract

The recognition that the increase of plasma triglyceride rich lipoproteins (TRLs) is associated with multiple alterations of other lipoproteins species that are potentially atherogenic has expanded the picture of diabetic dyslipidaemia. The discovery of heterogeneity within major lipoprotein classes VLDL, LDL and HDL opened new avenues to reveal the specific pertubations of diabetic dyslipidaemia. The increase of large VLDL 1 particles in Type 2 diabetes initiates a sequence of events that generates atherogenic remnants, small dense LDL and small dense HDL particles. Together these components comprise the atherogenic lipid triad. Notably the malignant nature of diabetic dyslipidaemia is not completely shown by the lipid measures used in clinical practice. The key question is what are the mechanisms behind the increase of VLDL 1 particles in diabetic dyslipidaemia? Despite the advances of recent years, our understanding of VLDL assembly and secretion is still surprisingly incomplete. To date it is still unclear how the liver is able to regulate the amount of triglycerides incorporated into VLDL particles to produce either VLDL 1 or VLDL 2 particles. The current evidence suggests that the machinery driving VLDL assembly in the liver includes (i) low insulin signalling via PI-3 kinase pathway that enhances lipid accumulation into "nascent " VLDL particles (ii) up-regulation of SREBP-1C that stimulates de novo lipogenesis and (iii) excess availability of "polar molecules" in hepatocytes that stabilizes apo B 100. Recent data suggest that all these steps could be fundamentally altered in Type 2 diabetes explaining the overproduction of VLDL apo B as well as the ability of insulin to suppress VLDL 1 apo B production in Type 2 diabetes. Recent discoveries have established the transcription factors including PPARs, SREBP-1 and LXRs as the key regulators of lipid assembly in the liver. These observations suggest these factors as a new target to tailor more efficient drugs to treat diabetic dyslipidaemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-003-1111-y

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Self-citation
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014

Show all 183 references

Sorted by citations

Items 801–885 of 885

Study the changes in levels of lipid profile and liver enzymes in type 2 DM
Hussein, M. A. A. (2022) · AIP conference proceedings · doi:10.1063/5.0067077
Relationships Between Serum Lipoprotein (a) And Sarcopenia In ElderlyPreprint
Xu, L., Zhou, L., Xiao, Q., Chen, J., Luo, C., Lyu, Q., Zhao, Y., Sun, Y., Zhou, T., & Zhao, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1151264/v1
Diabetic Dyslipidaemia
Vergès, B. L. (2022) · doi:10.1093/med/9780198870197.003.0282
Current literature in diabetes
(2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.351
Gynostemma Pentaphyllum Ameliorates Lipid Metabolic Abnormalities in Diabetic Kidney DiseasePreprint
Wang, P., Jiao, S., Sun, L., Sun, H., Wang, C., Sun, H., & Zhang, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-1149570/v2
The current state of diabetes treatment
Danquah, M. K., & Jeevanandam, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85396-5.00007-5
Désordres cliniques et biologiques associés
(2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75889-8.00005-1
The relationship of GDF-15 with renal damage and dyslipidemia in non-albuminuric and albuminuric Type-2 Diabetes MellitusPreprint
Yücel, H. E., & İlanbey, B. (2022) · Research Square · doi:10.21203/rs.3.rs-1681859/v1
A Pattern of Lipid Profile Among Saudi Adults With Type 1 Diabetes Mellitus in a Tertiary Hospital: A Retrospective Study
Alshahrani, A. S., Alibrahim, A. R., Alanazi, M., Omair, A. A., Alsadhan, M. A., Alattiah, T. M., Kanadily, F. A., Alattiah, S. M., & Mahzari, M. M. (2022) · Cureus · doi:10.7759/cureus.25622
Parâmetros metabólicos, inflamatórios e de saciedade de gatos obesos alimentados com dieta com adição de beta-glucanos
Risolia, L. W. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2021.tde-13122021-165956
Magnitude of dyslipidemia in type 2 diabetes
Das, C., & Sahana, P. K. (2022) · Annals of Medical Science and Research · doi:10.4103/amsr.amsr_29_22
Investigation of the Relationship between the rs8192688 Polymorphism of the FABP-4 Gene and Cardiovascular Disease Susceptibility in Type 2 Diabetic Patients in Ilam Province, Iran
Bakhtiyari, A., Bakhtiari, S., Peymani, M., Haghani, K., & Norozi, S. (2022) · journal of ilam university of medical sciences · doi:10.52547/sjimu.30.2.97
Glipizide has Low Influences on Lipid Index and Major Organs Weight Variation and Considerable Anxiolytic Properties: An in vivo Investigation
Salam, M. A., Rana, M. F., Baral, P. K., Rahman, M., Ahmed, S., Rahman, R., Jahan, N., Mazumder, T., Islam, M. S., & Hussain, M. S. (2023) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2023.7.17
Lipoproteins and Diabetic Kidney Disease
Sigfrids, F. J., Elonen, N., & Groop, P. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_15
Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes Mellitus Type 2
Brinton, E. A., & Pulipati, V. P. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_24
Effect of the Aqueous Extract of Corchorus olitorius L. on the Lipid Parameters of Rats Subjected to a Hyperlipidic Diet
Delor, K. K. C., Raoul, B. K. K., & Bognan, A. J. A. A. (2023) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2023/v32i6818
Associação de obesidade e subfrações de LDL avaliadas por índice de massa corpórea, circunferência abdominal e diabetes: o estudo Elsa Brasil
Moraes, E. G. (2023) · doi:10.11606/t.5.2023.tde-19102023-164607
Optimisation of ultrasonic-assisted hot-water extraction conditions of soluble dietary fibre from Lentinula edodes and analysis of its hypolipidaemic and anti-inflammatory properties in STZ-induced diabetic mice
Ni, Z., Li, J. T., Qian, X. Y., Yong, Y. D., Lv, W. D., Wang, Y. N., Zhang, S. M., Sun, H. K., Peng, G., Shao, Y., et al. (2023) · Acta Alimentaria · doi:10.1556/066.2023.00128
Cardiometabolic Function in Women
Joksimović, J., Novakovic, J. N., Jeremic, N. S., & Bradić, J. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-39928-2_12
Long duration of diabetes is associated with inadequate glycemic control and lipid profile
Bharti, R. K. (2023) · Journal of Research in Applied and Basic Medical Sciences · doi:10.61186/rabms.9.4.210
Impaired Physiological Regulation of ß Cells: Recent Findings from Type 2 Diabetic Patients
Irfan, S., Muzaffar, H., Mukhtar, I., Jabeen, F., & Anwar, H. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1003752
The high-density lipoprotein: Attribute matters rather than amount in therapeutic arena
AlJadir, S. J. (2023) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2023.11.00334
Evaluation of Serum Triglyceride and TG/HDL-Cholesterol Ratio in Good and Poor Control Type-2 Diabetes Mellitus
Sultana, D., Roy, M. N., Karmakar, P., Zohora, F. T., Hoque, M. E., & Sharna, R. J. (2024) · Eastern Medical College Journal · doi:10.3329/emcj.v9i1.71975
How safe are proprotein convertase subtilisinekexin type 9 inhibitors in diabetes?
Chen, T., & Liu, N. (2024) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000934
Risk prediction of Type 2 diabetes mellitus and obesity among the medical students in a tertiary care hospital of Pondicherry by using IDRS
Jafrin, M. M. (2024) · Journal of Dr. YSR University of Health Sciences. · doi:10.4103/jdrysruhs.jdrysruhs_142_21
Avaliação de miRNAs circulantes e sua associação com remissão de diabetes mellitus tipo 2 em mulheres com obesidade submetidas à derivação gástrica em Y de Roux
Martinez, A. C. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-19062024-150955
Aggravated dyslipidemia in diabetic albino rats after subchronic oral aluminium chloride exposure
Igwenagu, E., Egbe-Nwiyi, T. N., & Igbokwe, I. O. (2024) · Comparative Clinical Pathology · doi:10.1007/s00580-024-03598-y
Analysis and correlation of Blood HbA1c percentages with microalbuminuria and dyslipidemia among diabetes in a tertiary care multi-speciality hospital of Eastern India
Saurajit, D., Ayonava, S., Kalyan, M., & Pathak, I. (2023) · Journal of Applied Biochemistry & Laboratory Medicine · doi:10.5005/jablm-11031-04108
Association between duration of diabetes and fasting lipid profile in Bangladeshi type-2 diabetic patients: a series of hundred one cases
Siddiqui, S. R. A., & Rahman, M. Z. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20251683
Pharmacological and pathological ameliorating effect of freeze-dried Kaempferia galanga herbal supplementation on hyperglycemia-induced dyslipidemia in Balb/c diabetic mice
Nonglang, F. P., & Bhan, S. (2025) · Vegetos · doi:10.1007/s42535-025-01339-2
Relationship Between HbA1c Levels and Thickness of Carotis Intima Media in Prediabetic and Diabetic PatientsPreprint
Murat, A. Y., & Sarı, A. (2025) · Research Square · doi:10.21203/rs.3.rs-6999939/v1
Clinical-laboratory evaluation of overweight and obese cats seen in routine clinical practice
Araújo, S. L., Martins, P. L., Pereira, T. H. D. S., da Silva, I. N. G., de Morais, G. B., & Evangelista, J. S. A. M. (2025) · Pesquisa Veterinária Brasileira · doi:10.1590/1678-5150-pvb-7448 · Cited by 1
Hemoglobin glycation index and triglyceride glucose index as potential markers for prediction of diabetic vascular complications
Ghorab, R. A., Salem, L. E. M. A., Mohamed, M. F., Omran, A., Adel, S., Abdalgeleel, S. A., Alshehri, M., Othman, B. A., Aljadani, S. H., Elsheikh, D. H. H., et al. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00499-6
Association of Serum Thyroid Profile and Glycated Hemoglobin Levels in Diabetic Patients: A Cross-Sectional Study
Baruah, J., Kalita, S., Kumar, P., Gupta, A., Lahon, D., & Sarmah, J. (2025) · Cureus · doi:10.7759/cureus.92213
Calculated Excess-Triglyceride Based on the Friedewald Formula is a Possible Surrogate Marker for the Production of Large Very-Low Density Lipoprotein, A Post-Hoc Analysis of the PROUD48 Study
Hirano, T., Takeda, Y., Sakuma, I., Hiramitsu, S., Okada, M., Ueda, S., & Sakurai, M. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65870
Unmasking the Emotional and Behavioral Determinants of Glycemic Control in Diabetes Management
Ganguly, S., Mohanty, I. R., & Rai, S. (2025) · Cureus · doi:10.7759/cureus.92635
Medication-Stratified Analysis of LDL-C Equation Miscalibration in Diabetes: Evidence from the All of Us Research Program and a Medication-Agnostic Machine-Learning CorrectionPreprint
Doku, R., Osafo, N. Y., Kwagyan, J., & Southerland, W. M. (2025) · medRxiv · doi:10.1101/2025.10.23.25338682
Serum PCSK9 is not independently associated with dyslipidaemia in type 2 diabetes: a paired cross-sectional study
Okoro, P. N., Wahab, K. W., Olarinoye, J. K., & Abayomi, B. S. (2025) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-025-00253-5
The association between APOA1 (rs5069) gene polymorphism and insulin resistance surrogates and metabolic indices among obese individuals with different glycemic statuses (euglycemic and T2DM)
Usama, N., Ahmed, A. E., Mekheimer, S., Elhadidy, K., & Farid, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-30630-0 · Cited by 1
Primär- und Sekundärprävention der KHK bei Diabetes mellitus
Parhofer, K. G. (2005) · Der Diabetologe · doi:10.1007/s11428-005-0017-3
Additional file 1 of Association between non-high-density lipoprotein to high-density lipoprotein ratio and reversion to normoglycemia in people with impaired fasting glucose: a 5-year retrospective cohort study
Mo, Z., Han, Y., Cao, C., Huang, Q., Hu, Y., Yu, Z., & Hu, H. (2024) · Figshare · doi:10.6084/m9.figshare.26655253
Additional file 1 of Supra-additive effect of chronic inflammation and atherogenic dyslipidemia on developing type 2 diabetes among young adults: a prospective cohort study
Lan, Y., Wu, D., Cai, Z., Xu, Y., Ding, X., Wu, W., Lan, S., Chen, L., Guo, Z., Balmer, L. A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23691216
Additional file 1 of Measurement of cumulative high-sensitivity C-reactive protein and monocyte to high-density lipoprotein ratio in the risk prediction of type 2 diabetes: a prospective cohort study
Wu, D., Chen, G., Lan, Y., Chen, S., Ding, X., Wei, C., Balmer, L. A., Wang, W., Wu, S., & Xu, W. (2024) · Figshare · doi:10.6084/m9.figshare.25101097
Additional file 1 of Temporal relationship between atherogenic dyslipidemia and inflammation and their joint cumulative effect on type 2 diabetes onset: a longitudinal cohort study
Lan, Y., Chen, G., Wu, D., Ding, X., Huang, Z., Wang, X., Balmer, L. A., Li, X., Song, M., Wang, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22600996
Additional file 1 of ANGPTL3 is a novel HDL component that regulates HDL function
Yang, L., Wang, Y., Xu, Y., Li, K., Yin, R., Zhang, L., Wang, D., Wei, L., Lang, J., Cheng, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26691460
Additional file 1 of The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis
Lin, T., Xia, X., Yu, J., Qiu, Y., Yi, C., Lin, J., Mao, H., Yang, X., & Huang, F. (2020) · Figshare · doi:10.6084/m9.figshare.12016542
Additional file 1 of Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63)
Bourgonje, A. R., Connelly, M. A., van Goor, H., van Dijk, P. R., & Dullaart, R. P. F. (2024) · Figshare · doi:10.6084/m9.figshare.26602642
Pharmacological Evaluation of Carvacrol Loaded Cubosomes against HFD-STZ Induced Diabetic Nephropathy in Rats
Ahire, Y., Patil, D., Birhade, H., Pawar, A., Ahire, S., Pathade, P., & Bairagi, V. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10288-x
Serum Lipid Levels in Patients with Diabetic Retinopathy
Başdoğan, B., Şahinoğlu-Keşkek, N., Özilice, U., Raufoğlu, C., Özilice, Ö., & Keşkek, Ş. Ö. (2025) · Acta Medica Alanya · doi:10.30565/medalanya.1732116
Antidiabetic and Lipid-Modulating Activities of Solvent Fractions of Methanolic Bark Extract of Euphorbia tirucalli in Alloxan-Induced Diabetic Rats
Danamurthy, N., & Rao, N. V. R. (2025) · Toxicology International · doi:10.18311/ti/2025/v32i4/50272
Lipid Profile of Type 2 Diabetic Patients at Sylvanus Olympio University Hospital in Lome
Mossi, K. E., Djalogue, L., Djagadou, K. A., Tchamdja, T., Maman, S., Apeti, S., Nebona, L., Gumedzoe, E., Balaka, A., & Djibril, M. A. (2026) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2026.161001
CORRELATION OF SERUM URIC ACID WITH LIPID PROFILE AND GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS
Singh, A. K., RAHI, R., KUMAR, C., SINGH, P. K., & KUMAR, S. (2026) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2026v18i1.8042
Réentraînement à l'effort chez des sujets atteints du syndrome métabolique : impact sur les réponses hormonales et la qualité de vie
Baillot, A. (2010) · theses.fr (ABES) · doi:10.70675/967a5fa2z70aez4e42za0eez643f3cd42d64
Effets des différentes techniques de chirurgie bariatrique sur le métabolisme des lipoprotéines riches en triglycérides(LRT) intestinales et hépatiques chez le patient obèse
Padilla, N. (2014) · theses.fr (ABES) · doi:10.70675/d0d25e1ez35f7z44f5z8ed8z8283dae28540
Etudes des effets cardio-métaboliques d'une aminopyrroline sympatho-inhibitrice dans un modèle de syndrome métabolique chez le primate non humain : mise en évidence des mécanismes d’action impliqués
Weiss, M. (2016) · theses.fr (ABES) · doi:10.70675/a69e0898z2496z471az97bdz0fb3958d4324
Hypertriglycéridémie postprandiale : signature microARN et insulino-résistance
housseini, R. E. (2019) · theses.fr (ABES) · doi:10.70675/7d24ea93z83a6z478aza78dzaa7adafeb958
Lipoprotéines riches en triglycérides chez le patient diabétique de type 2 : Effets sur l'activation plaquettaire et profil sphingolipidomique
Boulet, M. M. (2020) · theses.fr (ABES) · doi:10.70675/5f361957z46f8z477ez955fze63a4ef64f06
Étude de bioactivité, de bioconversion et d’absorption par cellules CACO-2 d’un principe actif d’origine végétale pour la prévention du diabète de type 2
Haguet, Q. (2021) · theses.fr (ABES) · doi:10.70675/d41afb26z3461z49fdza225zb7758bb535b8
Rôle des sphingolipides hépatiques dans la physiopathologie du diabète de type 2
Lachkar, F. (2022) · theses.fr (ABES) · doi:10.70675/2f1ce169zade5z47ccz96caz55bf77edab09
Comprehensive assessment of health disparities in tribal and non-tribal population in India: a sex- and age-stratified cross-sectional study
Ratre, Y. K., Dave, B., Joshi, M., Bagatharia, S. B., Shah, T., Samova, S., Joshi, C. G., Patel, A. K., & Prajapati, B. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1772205
Exploring the Mechanism of San Jie Tong Mai Formula Against Atherosclerosis via Network Pharmacology and Proteomics
Han, H., Li, H., Zhou, Z., Liu, A., Zhong, C., & Sun, Y. (2026) · Journal of Visualized Experiments · doi:10.3791/70080
Evaluation of correlation of GDF11 and atherogenic factors in patients with diabetic dyslipidemia
Ghafil, N. Y., & Ali, S. H. I. A. (2026) · Polski Merkuriusz Lekarski · doi:10.36740/merkur202602107
Dapagliflozin is associated with a reduction in left atrial volume index in type 2 diabetes mellitus without established cardiovascular disease
Çakır, B., Polat, F., Karataş, M. B., Dayı, Ş. Ü., Öz, A., Engin, İ., Kahraman, E., & Demirbaş, Z. E. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02707-3
Association of Continuous Glucose Monitoring with Glycaemic, Distress, and Quality of Life Outcomes in Insulin-Treated Type 2 Diabetes: A 12-Month Prospective Study
Dzojic, K., Schönberger, E., Petrinović, M., Rimac, D. S., Erzic, E., Berković, M. C., Bakula, M., Bilić-Čurčić, I., & Canecki-Varžić, S. (2026) · Medicina · doi:10.3390/medicina62050938
Correlation Between Fasting Blood Glucose and Serum Lipid Profile and Lipid Ratios in Patients with Type 2 Diabetes Mellitus in Southern Thailand: A Cross-Sectional Study
Sukkriang, N., Sangpoom, S., & Khumphairan, S. (2026) · Medical Sciences · doi:10.3390/medsci14020302 · Cited by 1
Dyslipidemia in Patients with Type 2 Diabetes Mellitus Attending Bir Hospital, NAMS, Nepal
Shrestha, S., & shrestha, A. (2025) · Dinkum Journal of Medical Innovations · doi:10.71017/djmi.4.9.d-0492
Quantitative metabolomics and machine learning identify differential metabolomic biomarkers across normoglycaemia, pre-diabetes and diabetes in a Qinghai Plateau population
Li, T., Zhang, B., Huang, Q., Xu, R., Gao, H., Shi, L., Wang, H. J., Zhao, L., Tang, H., Wang, Y., et al. (2026) · BMJ Public Health · doi:10.1136/bmjph-2025-004416
Mesures nutritionnelles dans les hypertriglycéridémies : théorie bien définie, pratique complexe
Monnier, L., Schlienger, J.-L., & Colette, C. (2026) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2026.06.004
Association of triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein to high-density lipoprotein cholesterol ratios with glycemic control in type 2 diabetes mellitus: A cross-sectional study from a Libyan clinical cohort
Mahmoud, S. H., Elfargani, F. R., Mohamed, N., & Khader, Y. (2026) · Medicine · doi:10.1097/md.0000000000049337
Metabolic Benefits of Saroglitazar 4 mg in Type 2 Diabetes Mellitus With Dyslipidemia: A Retrospective Real-World Observational Cohort Study From India
Jagadeesha, A., Bhattacharya, S., SHRIVASTAVA, A., Samajdar, S. S., Gunjan, G., Bhardwaj, S., & TELANG, S. (2026) · Cureus · doi:10.7759/cureus.111328
hs-CRP/HDL Ratio Across Obesity and Type 2 Diabetes Mellitus Phenotypes in Adults: A Cross-Sectional Study
Solomon, C. C., Palade, N. A., Gligor, F. G., Pintea, A. L., Morgovan, C., Frum, A., Butucă, A., Dobrea, C. M., Dadarlat, D. A., & Tilinca, M. C. (2026) · Diagnostics · doi:10.3390/diagnostics16132013
Association of genome-wide association study–derived type 2 diabetes risk variant VPS26A rs1802295 with dyslipidemia: a pilot study from North India
Shakir, Z., Himanshu, D., Pandey, A., Siddiqui, K. U., & Ali, W. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-026-01714-y
The Nonlinear Association Between Adipose Tissue Insulin Resistance and Remnant Cholesterol in Chinese Adults: A Cross-Sectional Study
Cui, R., Sun, H., Yang, M., Wang, Y., Liu, J., & Wang, G. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13090459
Aucubin Ameliorates Alloxan-Induced Diabetic Liver Injury in Association with Modulation of the Nrf2/HO-1 Antioxidant Axis and NF-κB-Associated Inflammatory and Apoptotic Signaling
Hamed, A. M., Mahrous, N. S., Soliman, S. S., Ali, L. ِ., Refaei, R. A., Beshay, O. N., Osman, A. S., Hamouda, M. E. E. M., Elmahdy, S. M., Mohamed, S. M., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188184
Remnant clearance capacity: a new framework for early type 2 diabetes pathogenesis
Nakajima, K., Murakami, M., & Tanaka, A. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121345
Assessment of Lipid Profiles, Thyroxin and Uric Acid Levels in Patients with Type 2 Diabetes Mellitus in Taiz, Yemen
Al-Hammadi, M. A., Ahmed, R. H., Pyar, H., Saleh, A. A., Najee, M. A., Ahmed, A. H., Ahmed, M. F., & Mahyoub, F. A.-R. A. (2026) · Journal of Applied Sciences · doi:10.3923/jas.2026.16.27
Associations of IDL cholesterol and LDL α-tocopherol with diabetic kidney disease in type 2 diabetes
Hirowatari, Y., Iwasaki, T., Manita, D., Hakoshima, M., Katsuyama, H., & Yanai, H. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113571
Promising antidiabetic potential of traditionally used plant Coccinia indica in streptozotocin-induced diabetic rat model
Rahman, A., Khan, A. A., Ahmad, S., Qadeer, M. A., Shabnam, & Naseem, S. (2026) · Annals of the National Academy of Medical Sciences (India) · doi:10.25259/anams_246_2024
Serum periostin as a novel biomarker of metabolic and atherogenic risk in newly diagnosed type 2 diabetes mellitus with dyslipidemia
Jafer, A. A. J., Hussein, H. J., Hasan, N. K., Ahmed, N. N., & Turki, Z. A. A. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-02095-z
Benevolent Role of Spices in Management of Metabolic Syndrome
Patel, K., Patil, S., Patel, V., Trivedi, R., & Maheshwari, R. (2026) · Journal of Natural Remedies · doi:10.18311/jnr/2026/52732
Remnant Lipoproteins as Dynamic Metabolic States: A Residence Time–Based Framework for TRL Metabolism
Nakajima, K., Murakami, M., & Tanaka, A. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101173
BindingDB Entry 50001977: Dual antioxidant structures with potent anti-inflammatory, hypolipidemic and cytoprotective properties.
BindingDB (2020) · UC San Diego · doi:10.7270/q29g5qcr
AVALIAÇÃO DO SINAL INSULÍNICO EM RATOS ADULTOS COM LESÃO PERIAPICAL
Astolphi, R. D. (2013) · Americanae (AECID Library)
Lipoprotein Metabolism and Alterations Induced by Insulin Resistance and Diabetes
TOMKIN, G. H., & Owens, D. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_5
The role of PPARalpha and growth hormone in hepatic lipid metaboism and atherosclerosis
Ljungberg, A. (2006) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Authors: Taskinen, M.-R.
Affiliations: University of Helsinki (FI)
Corresponding author: Taskinen, M.-R.
ORCID: Taskinen, M.-R.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2003-06-01
Volume: 46
Issue: 6
Pages: 733-749
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-003-1111-y
OpenAlex: W2020659754
Cited by: 888
References: 183
Citations by year: 2026: 27 · 2025: 37 · 2024: 32 · 2023: 36 · 2022: 48 · 2021: 41 · 2020: 39 · 2019: 27 · 2018: 32 · 2017: 28 · 2016: 29 · 2015: 47 · 2014: 41 · 2013: 46 · 2012: 42
FWCI: 6.10
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
Academy of Finland
Diabetesliitto
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: diabetic dyslipidemia, type 2 diabetes, small dense LDL, triglyceride-rich lipoproteins, VLDL assembly, hepatic lipid metabolism, insulin signaling, PI3-kinase, SREBP-1c, de novo lipogenesis, apolipoprotein B-100, peroxisome proliferator-activated receptors, SREBP1, liver X receptor
MeSH terms: Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hyperlipidemias, Lipoproteins, Lipoproteins, VLDL, Diabetes Complications, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetic dyslipidaemia: from basic research to clinical practice*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks